Connie M Westhoff
Overview
Explore the profile of Connie M Westhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
1393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cezar-Schmidt A, Jean J, Lee P, Vege S, Westhoff C, Hudgins J
Transfusion
. 2024 Nov;
65(1):E4-E6.
PMID: 39529456
No abstract available.
2.
Walker R, Barreto M, Bateman J, Bustamante M, Chiu G, Feitell S, et al.
Front Neurosci
. 2024 Sep;
18:1408105.
PMID: 39315078
XK disease is a very rare, multi-system disease, which can present with a wide spectrum of symptoms. This disorder can also be identified pre-symptomatically with the incidental detection of serological...
3.
Chou S, Mewha J, Friedman D, Lazariu V, Makrm S, Ochoa G, et al.
Blood
. 2024 Aug;
144(19):2045-2049.
PMID: 39172743
Anti-D can occur in D-positive patients who inherit RHD genetic variants encoding partial D antigen expression, but unexpected anti-D is also found in the plasma of patients with sickle cell...
4.
Westhoff C, Floch A
Br J Haematol
. 2024 Aug;
206(1):18-32.
PMID: 39104129
The last decade has seen significant growth in the application of DNA-based methods for extended antigen typing, and the use of gene sequencing to consider variation in blood group genes...
5.
Lane W, Vege S, Mah H, Ochoa-Garay G, Lomas-Francis C, Westhoff C
Transfusion
. 2024 Jul;
64(9):1633-1639.
PMID: 39051122
Background: The Er blood group system was recently shown to be defined by PIEZO1. The system consists of high prevalence antigens Er, Er3, ERSA, and ERAMA; and low prevalence antigen...
6.
Chang T, Yu J, Wang Z, Hankins J, Weiss M, Wu G, et al.
Blood Adv
. 2024 Mar;
8(11):2651-2659.
PMID: 38522094
Rh phenotype matching reduces but does not eliminate alloimmunization in patients with sickle cell disease (SCD) due to RH genetic diversity that is not distinguishable by serological typing. RH genotype...
7.
McGrath K, Koniski A, Murphy K, Getman M, An H, Schulz V, et al.
bioRxiv
. 2024 Feb;
PMID: 38370741
The limited proliferative capacity of erythroid precursors is a major obstacle to generate sufficient numbers of in vitro-derived red blood cells (RBC) for clinical purposes. We and others have determined...
8.
Israelyan N, Vege S, Friedman D, Zhang Z, Uter S, Fasano R, et al.
Transfusion
. 2024 Jan;
64(3):526-535.
PMID: 38289184
Background: Red cell alloimmunization remains a challenge for individuals with sickle cell disease (SCD) and contributes to increased risk of hemolytic transfusion reactions and associated comorbidities. Despite prophylactic serological matching...
9.
Yu J, Walker R, Danek A, Westhoff C, Vege S, Itin I
J Mov Disord
. 2024 Jan;
17(2):226-229.
PMID: 38185097
No abstract available.
10.
Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy
Singh N, Staves J, Storry J, Dinoso J, Renard C, Doshi P, et al.
Transfusion
. 2023 Nov;
63(12):2377-2383.
PMID: 37970740
No abstract available.